Charles Russell Speechlys advised the shareholders of Medpass International, the leading European medical device CRO, regulatory and reimbursement consultancy, on the sale of the company to Icon plc, a NASDAQ listed global provider of drug and device development and commercialisation services.
Want to share your news with your industry? Submit a press release.
Top 1000 Companies Ranked by Revenue – in Multiple Sectors & Countries.
This transaction will further expand ICON’s global medical device and diagnostic research services.